|
CRVO CervoMed Inc 1053691 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-6,571,656.00 |
| Balance Sheet |
|
Current Assets
|
$25,992,471.00 |
|
Assets
|
$25,992,471.00 |
|
Current Liabilities
|
$4,656,117.00 |
|
Liabilities
|
$3,032,174.00 |
|
Equity
|
$22,960,297.00 |
|
Shares Out
|
13526233.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-14,936,763.00 |
|
Investing Cash Flow
|
$10,236,908.00 |
| Market Analysis |
Market Cap
|
$34,627,156.48 |
|
Price
|
$2.56 |
|
BVPS
|
1.70 |
|
PB
|
1.51 |
|
EPS
|
-0.64 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:56 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:46 |
|
| Apr |
May |
Jun |
| 2026-03-13 |
-2.98 |
|
|
2026-05-18 |
|
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-07 |
-0.84 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CRVO documents filed with the SEC.
CRVO Filings
Clear
